This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hakanen, A.
Right arrow Articles by Huovinen, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hakanen, A.
Right arrow Articles by Huovinen, P.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 1999, p. 3572-3577, Vol. 37, No. 11
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Detection of Decreased Fluoroquinolone Susceptibility in Salmonellas and Validation of Nalidixic Acid Screening Test

Antti Hakanen,1,2,* Pirkko Kotilainen,2 Jari Jalava,1 Anja Siitonen,3 and Pentti Huovinen1

Antimicrobial Research Laboratory, National Public Health Institute,1 and Department of Medicine, Turku University,2 Turku, and National Salmonella Reference Centre, Laboratory of Enteric Pathogens, National Public Health Institute, Helsinki,3 Finland

Received 6 April 1999/Returned for modification 14 June 1999/Accepted 11 August 1999

We evaluated 1,010 Salmonella isolates classified as fluoroquinolone susceptible according to the National Committee for Clinical Laboratory Standards guidelines for susceptibility to nalidixic acid and three fluoroquinolones. These isolates were divided into two distinct subpopulations, with the great majority (n = 960) being fully ciprofloxacin susceptible and a minority (n = 50) exhibiting reduced ciprofloxacin susceptibility (MICs ranging between 0.125 and 0.5 µg/ml). The less ciprofloxacin-susceptible isolates were uniformly resistant to nalidixic acid, while only 12 (1.3%) of the fully susceptible isolates were nalidixic acid resistant. A similar association was observed between resistance to nalidixic acid and decreased susceptibility to ofloxacin or norfloxacin. A mutation of the gyrA gene could be demonstrated in all isolates for which the ciprofloxacin MICs were >= 0.125 µg/ml and in 94% of the nalidixic acid-resistant isolates but in none of the nalidixic acid-susceptible isolates analyzed. Identification of nalidixic acid resistance by the disk diffusion method provided a sensitivity of 100% and a specificity of 87.3% as tools to screen for isolates for which the MICs of ciprofloxacin were >= 0.125 µg/ml. We regard it as important that microbiology laboratories endeavor to recognize these less susceptible Salmonella strains, in order to reveal their clinical importance and to survey their epidemic spread.

* Corresponding author. Mailing address: Antimicrobial Research Laboratory, National Public Health Institute, P.O. Box 57, 20521 Turku, Finland. Phone: 358-2-2519255. Fax: 358-2-2519254. E-mail: antti.hakanen{at}utu.fi.

Journal of Clinical Microbiology, November 1999, p. 3572-3577, Vol. 37, No. 11
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Gunell, M., Webber, M. A., Kotilainen, P., Lilly, A. J., Caddick, J. M., Jalava, J., Huovinen, P., Siitonen, A., Hakanen, A. J., Piddock, L. J. V. (2009). Mechanisms of Resistance in Nontyphoidal Salmonella enterica Strains Exhibiting a Nonclassical Quinolone Resistance Phenotype. Antimicrob. Agents Chemother. 53: 3832-3836 [Abstract] [Full Text]  
  • Morris, S. K., Richardson, S. E., Sauve, L. J., Ford-Jones, E. L., Jamieson, F. (2009). Increasing Fluoroquinolone Resistance in Salmonella typhi in Ontario, 2002-2007. Am J Trop Med Hyg 80: 1012-1013 [Abstract] [Full Text]  
  • Zheng, J., Cui, S., Meng, J. (2009). Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium. J Antimicrob Chemother 63: 95-102 [Abstract] [Full Text]  
  • Murray, A., Mather, H., Coia, J. E., Brown, D. J. (2008). Plasmid-mediated quinolone resistance in nalidixic-acid-susceptible strains of Salmonella enterica isolated in Scotland. J Antimicrob Chemother 62: 1153-1155 [Full Text]  
  • Kadhiravan, T., Wig, N., Renuka, K., Kapil, A., Kabra, S. K., Misra, A. (2008). Is nalidixic acid resistance linked to clinical virulence in Salmonella enterica serovar Typhi infections?. J Med Microbiol 57: 1046-1048 [Full Text]  
  • Vidyalakshmi, K, Yashavanth, R, Chakrapani, M, Shrikala, B, Bharathi, B, Suchitra, U, Dhanashree, B, Dominic, R M S (2008). Epidemiological shift, seasonal variation and antimicrobial susceptibility patterns among enteric fever pathogens in south India. Trop Doct 38: 89-91 [Abstract] [Full Text]  
  • Dimitrov, T., Udo, E. E., Albaksami, O., Al-Shehab, S., Kilani, A., Shehab, M., Al-Nakkas, A. (2007). Clinical and microbiological investigations of typhoid fever in an infectious disease hospital in Kuwait. J Med Microbiol 56: 538-544 [Abstract] [Full Text]  
  • Chen, S., Cui, S., McDermott, P. F., Zhao, S., White, D. G., Paulsen, I., Meng, J. (2007). Contribution of Target Gene Mutations and Efflux to Decreased Susceptibility of Salmonella enterica Serovar Typhimurium to Fluoroquinolones and Other Antimicrobials. Antimicrob. Agents Chemother. 51: 535-542 [Abstract] [Full Text]  
  • Dimitrov, T., Udo, E. E., Albaksami, O., Kilani, A. A., Shehab, E.-D. M. R. (2007). Ciprofloxacin treatment failure in a case of typhoid fever caused by Salmonella enterica serotype Paratyphi A with reduced susceptibility to ciprofloxacin. J Med Microbiol 56: 277-279 [Abstract] [Full Text]  
  • Kownhar, H., Shankar, E. M., Rajan, R., Rao, U. A. (2007). Emergence of nalidixic acid-resistant Salmonella enterica serovar Typhi resistant to ciprofloxacin in India. J Med Microbiol 56: 136-137 [Full Text]  
  • Turner, A. K., Nair, S., Wain, J. (2006). The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets. J Antimicrob Chemother 58: 733-740 [Abstract] [Full Text]  
  • Hakanen, A. J., Kotilainen, P., Pitkanen, S., Huikko, S., Siitonen, A., Huovinen, P. (2006). Reduction in fluoroquinolone susceptibility among non-typhoidal strains of Salmonella enterica isolated from Finnish patients. J Antimicrob Chemother 57: 569-572 [Abstract] [Full Text]  
  • Hakanen, A. J., Lindgren, M., Huovinen, P., Jalava, J., Siitonen, A., Kotilainen, P. (2005). New Quinolone Resistance Phenomenon in Salmonella enterica: Nalidixic Acid-Susceptible Isolates with Reduced Fluoroquinolone Susceptibility. J. Clin. Microbiol. 43: 5775-5778 [Abstract] [Full Text]  
  • Murray, A., Coia, J. E., Mather, H., Brown, D. J. (2005). Ciprofloxacin resistance in non-typhoidal Salmonella serotypes in Scotland, 1993-2003. J Antimicrob Chemother 56: 110-114 [Abstract] [Full Text]  
  • Kilmartin, D., Morris, D., O'Hare, C., Corbett-Feeney, G., Cormican, M. (2005). Clonal Expansion May Account for High Levels of Quinolone Resistance in Salmonella enterica Serovar Enteritidis. Appl. Environ. Microbiol. 71: 2587-2591 [Abstract] [Full Text]  
  • Levy, D. D., Sharma, B., Cebula, T. A. (2004). Single-Nucleotide Polymorphism Mutation Spectra and Resistance to Quinolones in Salmonella enterica Serovar Enteritidis with a Mutator Phenotype. Antimicrob. Agents Chemother. 48: 2355-2363 [Abstract] [Full Text]  
  • Perez-Vazquez, M., Roman, F., Aracil, B., Canton, R., Campos, J. (2004). Laboratory Detection of Haemophilus influenzae with Decreased Susceptibility to Nalidixic Acid, Ciprofloxacin, Levofloxacin, and Moxifloxacin Due to gyrA and parC Mutations. J. Clin. Microbiol. 42: 1185-1191 [Abstract] [Full Text]  
  • Ruiz, J. (2003). Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 51: 1109-1117 [Abstract] [Full Text]  
  • Hakanen, A., Jalava, J., Kotilainen, P., Jousimies-Somer, H., Siitonen, A., Huovinen, P. (2002). gyrA Polymorphism in Campylobacter jejuni: Detection of gyrA Mutations in 162 C. jejuni Isolates by Single-Strand Conformation Polymorphism and DNA Sequencing. Antimicrob. Agents Chemother. 46: 2644-2647 [Abstract] [Full Text]  
  • Liebana, E., Clouting, C., Cassar, C. A., Randall, L. P., Walker, R. A., Threlfall, E. J., Clifton-Hadley, F. A., Ridley, A. M., Davies, R. H. (2002). Comparison of gyrA Mutations, Cyclohexane Resistance, and the Presence of Class I Integrons in Salmonella enterica from Farm Animals in England and Wales. J. Clin. Microbiol. 40: 1481-1486 [Abstract] [Full Text]  
  • Schumacher, H., Hoffmann, S., Holmboe, C., Moller, J. K. (2001). A procedure for evaluation and documentation of susceptibility test methods using the susceptibility of Klebsiella pneumoniae to ciprofloxacin as a model. J Antimicrob Chemother 48: 493-500 [Abstract] [Full Text]  
  • Schumacher, H., Scheibel, J., Moller, J. K. (2000). Cross-resistance patterns among clinical isolates of Klebsiella pneumoniae with decreased susceptibility to cefuroxime. J Antimicrob Chemother 46: 215-221 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»